<DOC>
	<DOCNO>NCT00693485</DOCNO>
	<brief_summary>A multicenter , randomize , patient-masked , sham-controlled evaluation safety effect visual function brimonidine intravitreal implant patient glaucomatous optic neuropathy . Patients follow 1 year .</brief_summary>
	<brief_title>Safety Effects Brimonidine Intravitreal Implant Patients With Glaucomatous Optic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Primary openangle glaucoma one eye Visual acuity 20/80 good Intraocular pressure study eye â‰¤ 24 mm Hg Glaucomatous visual field loss 7 dB 25 dB Known allergy brimonidine tartrate Uncontrolled systemic disease infection eye Recent eye surgery injection eye Female patient pregnant , nurse planning pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>